GLP-1 is rapidly broken down and inactivated by the enzyme dipeptidyl peptidase-4 (DPP4), which is distributed throughout the body, both on the surface of cell membranes, and free in the bloodstream
You only have so much to give, right
The interplay between these systems offers insights into novel therapeutic targets
VSMC phenotypic switching is characterized by transformation from a quiescent contractile to an activated synthetic phenotype, promoting proliferation and leading to the formation of the neointima, the pathological vascular compartment critical for the development of atherosclerosis
Twice-daily may accelerate acute healing by 15-25%, but it also doubles how much of the peptide you use (and how much youre paying for a larger supply) Not necessarily a bad thing, but this consideration definitely has to be weighted against your specific situation and goals
It typically peaks during dose escalation and resolves within 1-2 weeks at each new dose level